XYLAPAN 20 mg/mL otopina za injekciju, za konja, govedo, psa i mačku
XYLAPAN 20 mg/mL otopina za injekciju, za konja, govedo, psa i mačku
Not authorised
- Xylazine hydrochloride
Product identification
Medicine name:
XYLAPAN 20 mg/mL otopina za injekciju, za konja, govedo, psa i mačku
Active substance:
- Xylazine hydrochloride
Target species:
-
Cattle
-
Dog
-
Cat
-
Horse
Route of administration:
-
Intramuscular use
-
Intravenous use
Product details
Active substance and strength:
-
Xylazine hydrochloride20.00/milligram(s)/millilitre1.00Vial
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cattle
-
Meat and offal1day
-
Milkno withdrawal periodN/A
-
-
-
Intravenous use
-
Horse
-
Meat and offal3day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN05CM92
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Croatia
Package description:
- Available only in Croatian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Vetoquinol Biowet Sp. z o.o.
Responsible authority:
- Ministry Of Agriculture Veterinary And Food Safety Directorate
Authorisation number:
- UP/I-322-05/13-01/600
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Croatian (PDF)
Published on: 9/02/2022